Pilot: Use of Rotem in revisions of hip arthroplasties: Changes in coagulation parameters?

• Conditions: blood coagulation; fibrinogen; 10005944

• Registration Number: NL-OMON40640
• Lead Sponsor: Isala Klinieken

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 15

Inclusion Criteria

all patients, older than 18 years, who will receive a total hip revision operation

Exclusion Criteria

patient refusal

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Changes in the Fibtem measurements of the Rotem</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Changes in the other parameters of the Rotem measurements </p><br>